Meeting occupational therapists face-to-face is always invaluable, and the recent Rise4Disability exhibition in Kent gave us the perfect opportunity to do just that. Many OTs were discovering eFOLDi for the very first time, and their feedback was both positive and packed with useful insights that we’re excited to share.
Lightweight design is a game-changer –Across the range, weight stood out as the most compelling feature. The eFOLDi Compass, at just 11kg (excluding battery), is the lightest four-wheel folding scooter on the market, whilst the Navigator powerchair (12.4kg) and Lite scooter (14kg) were also praised for their portability. OTs told us this level of lightness makes a huge difference by reducing carer strain and eliminating the need for expensive adapted vehicles.
- Storage matters – Ease of storage in flats and social housing was mentioned frequently, with compact designs seen as a significant advantage for clients in limited living spaces.
- The eFOLDi Lifter stood out – Many OTs responded positively to the eFOLDi Lifter, recognising its potential to make daily handling and transfers easier and safer.
- Narrow pavements require safer solutions – The slim profile of the eFOLDi Lite was recognised as an asset on older, narrower pavements in UK towns and villages. One OT even noted how bulkier scooters can tip or clip parked cars in such environments, highlighting the safety benefits of a more compact product.
- Home visits build confidence – OTs valued our approach of arranging home demonstrations, where they can attend alongside their clients. This collaborative model ensures the right product fit while building confidence for both therapist and client.
These insights underline how eFOLDi products address the real-world needs that OTs see daily; from reducing carer strain, to ensuring safer independent mobility.
For those who couldn’t attend the show, we’ve made our clinical reasoning documents and further resources available on our dedicated OT page where they can also arrange a home visit for your patients.